PPT-CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?
Author : pamella-moone | Published Date : 2018-11-04
IntroductionOverview Lowering HbA1c Reduces the Risk of Microvascular Complications But What About Macrovascular Complications December 2008 FDA Guidance on Evaluating
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "CV Risk Management in Diabetes: A Manda..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?: Transcript
Download Document
Here is the link to download the presentation.
"CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
